The FDA just approved its first treatment for COVID-19: an experimental antiviral drug called remdesivir that showed promise in preliminary research.
For the first time, the Food and Drug Administration (FDA) has granted its approval to a drug that seems to help COVID-19 patients.
Preliminary results from a government study suggest that remdesivir, an experimental antiviral drug, shortens the time it takes for coronavirus patients to recover by 31 percent, which translates to about four days.
